IBT
INCY icon

International Biotechnology Trust’s Incyte INCY Stock Holding History

International Biotechnology Trust’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$20.7M Hold
358,454
– – 6.97% 2
2023
Q2 		$22.3M Buy
358,454
+79,454
+28% +$5.31M 6.79% 2
2023
Q1 		$20.2M Buy
279,000
+50,000
+22% +$3.91M 5.63% 3
2022
Q4 		$18.4M Sell
229,000
-60,000
-21% -$4.59M 5.68% 3
2022
Q3 		$19.3M Buy
289,000
+270,919
+1,498% +$20M 6.17% 3
2022
Q2 		$238K Sell
18,081
-219,919
-92% -$16.7M 2.48% 15
2022
Q1 		$2.58M Sell
238,000
-47,000
-16% -$3.42M 0.58% 39
2021
Q4 		$20.9M Buy
285,000
+14,640
+5% +$987K 4.66% 4
2021
Q3 		$18.6M Buy
270,360
+133,500
+98% +$10.1M 4.48% 7
2021
Q2 		$11.5M Buy
136,860
+58,860
+75% +$4.91M 3.04% 12
2021
Q1 		$6.34M Hold
78,000
– – 1.68% 19
2020
Q4 		$6.78M Hold
78,000
– – 1.85% 18
2020
Q3 		$7M Hold
78,000
– – 2.26% 17
2020
Q2 		$7.99M Sell
78,000
-21,500
-22% -$2.07M 2.66% 15
2020
Q1 		$7.29M Buy
99,500
+35,500
+55% +$2.68M 3.32% 11
2019
Q4 		$5.59M Sell
64,000
-32,500
-34% -$2.78M 2.01% 16
2019
Q3 		$7.16M Buy
96,500
+17,500
+22% +$1.41M 3.31% 12
2019
Q2 		$6.71M Sell
79,000
-22,500
-22% -$1.81M 2.49% 15
2019
Q1 		$8.73M Sell
101,500
-153,000
-60% -$12.4M 3.22% 9
2018
Q4 		$12.7M Buy
254,500
+54,500
+27% +$3.54M 7.88% 1
2018
Q3 		$10.6M Buy
200,000
+74,025
+59% +$5.08M 5.03% 3
2018
Q2 		$8.44M Buy
125,975
+53,000
+73% +$3.62M 3.24% 12
2018
Q1 		$6.08M Hold
72,975
– – 2.37% 16
2017
Q4 		$6.91M Sell
72,975
-16,000
-18% -$1.67M 2.44% 14
2017
Q3 		$10.4M Buy
88,975
+11,500
+15% +$1.45M 4.04% 6
2017
Q2 		$9.76M Sell
77,475
-50,000
-39% -$6.36M 3.71% 7
2017
Q1 		$17M Buy
127,475
+48,700
+62% +$6.2M 6.52% 4
2016
Q4 		$7.9M Buy
+78,775
New +$7.69M 3.56% 10

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

International Biotechnology Trust's INCY Position: Q3 2023 in Review

International Biotechnology Trust held its Incyte (INCY) position steady in Q3 2023 at 358,454 shares worth $20.7M. The position accounts for 6.97% of the portfolio, ranked #2.

International Biotechnology Trust first reported a position in INCY in Q4 2016 and has held it in 28 quarters since. The position peaked at $22.3M in Q2 2023. 529 funds tracked by Wall St. Rank hold INCY as of Q3 2023.

  • International Biotechnology Trust held 358,454 shares of Incyte worth $20.7M as of Q3 2023.
  • International Biotechnology Trust left its Incyte share count unchanged in Q3 2023.
  • Incyte made up 6.97% of International Biotechnology Trust's portfolio in Q3 2023, its #2 holding.
  • International Biotechnology Trust first reported a position in Incyte in Q4 2016 and has held it in 28 quarters since.
  • International Biotechnology Trust's Incyte position peaked at $22.3M in Q2 2023.
  • 529 funds tracked by Wall St. Rank held Incyte as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.